rosuvastatin/omega-3 fatty acid (HCP 1007) / Hanmi  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rosuvastatin/omega-3 fatty acid (HCP 1007) / Hanmi
NCT01548157: Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule

Completed
1
28
RoW
HCP1007 / omarco and crestor
Hanmi Pharmaceutical Company Limited
Healthy
03/12
12/12
NCT01929070: A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007

Completed
1
12
RoW
HCP1007, Omarco and Crestor
Hanmi Pharmaceutical Company Limited
Healthy
03/13
03/13

Download Options